4//SEC Filing
BOBO DONALD E JR 4
Accession 0001225208-25-009841
CIK 0001099800other
Filed
Dec 9, 7:00 PM ET
Accepted
Dec 10, 6:58 PM ET
Size
10.3 KB
Accession
0001225208-25-009841
Insider Transaction Report
Form 4
BOBO DONALD E JR
CVP,Strategy/Corp Development
Transactions
- Exercise/Conversion
Common Stock
2025-12-10$59.26/sh+11,340$671,971→ 61,696.371 total - Sale
Common Stock
2025-12-10$83.83/sh−11,340$950,581→ 50,356.371 total - Exercise/Conversion
Employee Stock Option (Right to Acquire)
2025-12-10−11,340→ 45,360 totalExercise: $59.26From: 2019-06-08Exp: 2026-05-07→ Common Stock (11,340 underlying)
Holdings
- 38,817.699(indirect: By 401(k))
Common Stock
- 135,152(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 27, 2025.
- [F2]This transaction was executed in multiple trades at prices ranging from $83.465 to $84.100. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
Documents
Issuer
Edwards Lifesciences Corp
CIK 0001099800
Entity typeother
Related Parties
1- filerCIK 0001196661
Filing Metadata
- Form type
- 4
- Filed
- Dec 9, 7:00 PM ET
- Accepted
- Dec 10, 6:58 PM ET
- Size
- 10.3 KB